Mac Overmyer
In less experienced hands, robotic radical prostatectomy has the edge
In the hands of less experienced surgeons, robot-assisted laparoscopic radical prostatectomy has a lower perioperative morbidity rate and sound early oncologic outcomes compared to other surgical interventions.
Surveillance may be viable for small renal masses
Surgical treatment for small renal masses may be cautiously delayed in select patients with significant competing risks for mortality.
Percutaneous tibial nerve stimulation not cost-effective as primary overactive bladder therapy, according to study
Percutaneous tibial nerve stimulation is not a cost-effective means of treating overactive bladder as a primary intervention, but cost is not the only factor to consider when confronting OAB, and cost alone may not be a sufficient reason to avoid the therapy.
Robotic surgery offers good outcomes, but cost remains a factor
Advancing technology is pushing clinicians and patients into making ever more nuanced decisions between the costs of a procedure and its value.
Behavioral therapy found efficacious in post-radical prostatectomy men
Behavioral therapy can net significant improvements for men with incontinence post-radical prostatectomy, even in patients 5 years removed from surgery.
Sling placement during robotic sacrocolpopexy efficacious
Of the many questions raised by the advent of robot-assisted surgery, two are germane to robotic sacrocolpopexy: Does the technology increase the risk of stress urinary incontinence in women undergoing the robotic procedure, and if it does, should an anti-incontinence procedure accompany the primary procedure as prophylaxis against incontinence?
Durable success rates seen with mid-urethral sling
A retropubic mid-urethral sling showed a success rate of 81% and a satisfaction rate of 78% at an average follow-up of 68 months (range, 60-88 months) in a recent study.
Studies highlight complexity of benign prostatic hyperplasia, raise questions
A number of the leading studies that focus on the epidemiology, etiology, and treatment of BPH and lower urinary tract symptoms being presented at the upcoming AUA annual meeting seem to be characterized more by the questions they raise than by those they answer.
Biologic markers help assess bladder cancer risk
A pattern of biologic markers derived from peripheral blood samples can assess a patient's risk for bladder cancer with significant accuracy and reliability.


View Results